These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 7648000)

  • 1. Postprandial lipoprotein metabolism and atherosclerosis.
    Karpe F; Hamsten A
    Curr Opin Lipidol; 1995 Jun; 6(3):123-9. PubMed ID: 7648000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postprandial lipoproteins and atherosclerosis.
    Yu KC; Cooper AD
    Front Biosci; 2001 Mar; 6():D332-54. PubMed ID: 11229885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dietary cholesterol, cholesterol absorption, postprandial lipemia and atherosclerosis.
    Huff MW
    Can J Clin Pharmacol; 2003; 10 Suppl A():26A-32A. PubMed ID: 14571303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postprandial enrichment of remnant lipoproteins with apoC-I in healthy normolipidemic men with early asymptomatic atherosclerosis.
    Björkegren J; Silveira A; Boquist S; Tang R; Karpe F; Bond MG; de Faire U; Hamsten A
    Arterioscler Thromb Vasc Biol; 2002 Sep; 22(9):1470-4. PubMed ID: 12231568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disturbances in dietary fat metabolism and their role in the development of atherosclerosis.
    Weintraub M; Charach G; Grosskopf I
    Biomed Pharmacother; 1997; 51(8):311-3. PubMed ID: 9436521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postprandial accumulation of chylomicrons and chylomicron remnants is determined by the clearance capacity.
    Adiels M; Matikainen N; Westerbacka J; Söderlund S; Larsson T; Olofsson SO; Borén J; Taskinen MR
    Atherosclerosis; 2012 May; 222(1):222-8. PubMed ID: 22365426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxicity of remnants of triglyceride-rich lipoproteins: an atherogenic insult?
    Chung BH; Segrest JP
    Adv Exp Med Biol; 1991; 285():341-51. PubMed ID: 1858566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postprandial lipoprotein metabolism and atherosclerosis.
    Karpe F
    J Intern Med; 1999 Oct; 246(4):341-55. PubMed ID: 10583705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atherosclerotic risk factors in cardiovascular disease.
    LaRosa JC
    J Reprod Med; 1986 Sep; 31(9 Suppl):906-12. PubMed ID: 3772910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postprandial lipoprotein metabolism in normotriglyceridemic non-insulin-dependent diabetic patients: influence of apolipoprotein E polymorphism.
    Reznik Y; Pousse P; Herrou M; Morello R; Mahoudeau J; Drosdowsky MA; Fradin S
    Metabolism; 1996 Jan; 45(1):63-71. PubMed ID: 8544779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe defect in clearing postprandial chylomicron remnants in dialysis patients.
    Weintraub M; Burstein A; Rassin T; Liron M; Ringel Y; Cabili S; Blum M; Peer G; Iaina A
    Kidney Int; 1992 Nov; 42(5):1247-52. PubMed ID: 1453610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atherogenesis: a postprandial phenomenon.
    Zilversmit DB
    Circulation; 1979 Sep; 60(3):473-85. PubMed ID: 222498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triglyceride-rich lipoproteins in non-insulin-dependent diabetes mellitus: post-prandial metabolism and relation to premature atherosclerosis.
    De Man FH; Cabezas MC; Van Barlingen HH; Erkelens DW; de Bruin TW
    Eur J Clin Invest; 1996 Feb; 26(2):89-108. PubMed ID: 8904518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clearance of chylomicron triacylglycerol and cholesteryl ester from the plasma of streptozotocin-induced diabetic and hypercholesterolemic hypothyroid rats.
    Redgrave TG; Snibson DA
    Metabolism; 1977 May; 26(5):493-503. PubMed ID: 139529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Octogenarian subjects have low postprandial levels of chylomicron remnants: a possible explanation for protection against atherosclerosis.
    Weintraub M; Ringel Y; Rassin T; Arad J; Bodner G; Liron M
    J Gerontol; 1992 Nov; 47(6):B209-13. PubMed ID: 1430850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atherogenic nature of triglycerides, postprandial lipidemia, and triglyceride-rich remnant lipoproteins.
    Zilversmit DB
    Clin Chem; 1995 Jan; 41(1):153-8. PubMed ID: 7813071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An apolipoprotein(a) peptide delays chylomicron remnant clearance and increases plasma remnant lipoproteins and atherosclerosis in vivo.
    Devlin CM; Lee SJ; Kuriakose G; Spencer C; Becker L; Grosskopf I; Ko C; Huang LS; Koschinsky ML; Cooper AD; Tabas I
    Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1704-10. PubMed ID: 15905467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dietary fat and physiological determinants of plasma chylomicron remnant homoeostasis in normolipidaemic subjects: insight into atherogenic risk.
    Irawati D; Mamo JC; Slivkoff-Clark KM; Soares MJ; James AP
    Br J Nutr; 2017 Feb; 117(3):403-412. PubMed ID: 28215212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of triglyceride-rich lipoproteins in atherogenesis.
    Zilversmit DB
    Ann N Y Acad Sci; 1976; 275():138-44. PubMed ID: 188364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of atherosclerosis by human chylomicron remnants: a hypothesis.
    Wilhelm MG; Cooper AD
    J Atheroscler Thromb; 2003; 10(3):132-9. PubMed ID: 14564081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.